Effect of Praneem polyherbal formulations against Infection of HPV in Uterine cervix.
Phase 2
Completed
- Registration Number
- CTRI/2008/091/000043
- Lead Sponsor
- Indian Council of Medical Research, Ansari Nagar, New Delhi- 110 029
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Adult females in reproductive age group of 30 years or more with HPV infection or inflammatory lesions.
Exclusion Criteria
1) Pregnant Women
2) Patient with menstrual irregularities and any tumor or other concomitant therapies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disappearance of reduction of HPV DNA Disappearance of lesions on visual inspection, Disappearance of lesions on colposcopic examination.Timepoint: Time-points: 30 days
- Secondary Outcome Measures
Name Time Method Disappearance of lesions on cytology. Disappearance of lesions on colposcopic examination. Time-points: 30 daysTimepoint: Time-points: 30 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Praneem polyherbal formulations inhibit HPV viral replication in cervical epithelial cells?
How does the efficacy of Praneem Cream and tablets compare to standard antiviral therapies for high-risk HPV infections?
What are the primary clinical endpoints in CTRI/2008/091/000043 regarding HPV clearance and lesion regression in cervical cancer prevention?
Which biomarkers correlate with response to Praneem treatment in patients with HPV-positive cervical lesions?
Are there synergistic effects when combining Praneem with other herbal or conventional treatments for cervical HPV infections?